Publication: Antibodies against a Plasmodium falciparum RON12 inhibit merozoite invasion into erythrocytes
1
Issued Date
2019-02-01
Resource Type
ISSN
18730329
13835769
13835769
Other identifier(s)
2-s2.0-85055337712
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Parasitology International. Vol.68, No.1 (2019), 87-91
Suggested Citation
Daisuke Ito, Eizo Takashima, Tsutomu Yamasaki, Shinya Hatano, Tomoyuki Hasegawa, Kazutoyo Miura, Masayuki Morita, Amporn Thongkukiatkul, Mahamadou Diakite, Carole A. Long, Jetsumon Sattabongkot, Rachanee Udomsangpetch, Hideyuki Iriko, Tomoko Ishino, Takafumi Tsuboi Antibodies against a Plasmodium falciparum RON12 inhibit merozoite invasion into erythrocytes. Parasitology International. Vol.68, No.1 (2019), 87-91. doi:10.1016/j.parint.2018.10.006 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/51110
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Antibodies against a Plasmodium falciparum RON12 inhibit merozoite invasion into erythrocytes
Abstract
© 2018 Elsevier B.V. Proteins coating Plasmodium merozoite surface and secreted from its apical organelles are considered as promising vaccine candidates for blood-stage malaria. The rhoptry neck protein 12 of Plasmodium falciparum (PfRON12) was recently reported as a protein specifically expressed in schizonts and localized to the rhoptry neck of merozoites. Here, we assessed its potential as a vaccine candidate. We expressed a recombinant PfRON12 protein by a wheat germ cell-free system to obtain anti-PfRON12 antibody. Immunoblot analysis of schizont lysates detected a single band at approximately 40 kDa under reducing conditions, consistent with the predicted molecular weight. Additionally, anti-PfRON12 antibody recognized a single band around 80 kDa under non-reducing conditions, suggesting native PfRON12 forms a disulfide-bond-mediated multimer. Immunofluorescence assay and immunoelectron microscopy revealed that PfRON12 localized to the rhoptry neck of merozoites in schizonts and to the surface of free merozoites. The biological activity of anti-PfRON12 antibody was tested by in vitro growth inhibition assay (GIA), and the rabbit antibodies significantly inhibited merozoite invasion of erythrocytes. We then investigated whether PfRON12 is immunogenic in P. falciparum-infected individuals. The sera from P. falciparum infected individuals in Thailand and Mali reacted with the recombinant PfRON12. Furthermore, human anti-PfRON12 antibodies affinity-purified from Malian serum samples inhibited merozoite invasion of erythrocytes in vitro. Moreover, pfron12 is highly conserved with only 4 non-synonymous mutations in the coding sequence from approximately 200 isolates deposited in PlasmoDB. These results suggest that PfRON12 might be a potential blood-stage vaccine candidate antigen against P. falciparum.